AS29207
Takeda Pharmaceuticals U.S.A., Inc. — takeda.com
Summary
| Country |
 United States
|
| Organization | Takeda Pharmaceuticals U.S.A., Inc. |
| Domain | takeda.com |
| Number of IPv4 | 1,024 |
| Number of IPv6 | 0 |
| AS Type | Business |
| Registry | RIPE NCC |
| Allocated | July 01, 2003 (about 22 years ago) |
| Updated | February 23, 2021 (about 4 years ago) |
IP Ranges
AS29207 announces 4 IPv4 ranges and 0 IPv6 range.
That's a total of 1,024 IPv4 address and 0 IPv6 address.
| Prefix | Organization | Size | Registry | Status |
|---|---|---|---|---|
| 43.229.159.0/24 |
 BAXALTA-IE
|
256 | APNIC | ALLOCATED NON-PORTABLE |
| 67.131.130.0/24 |
SHIRE PHARMACEUTICALS
|
256 | ARIN | REASSIGNMENT |
| 195.216.225.0/24 |
Takeda Pharmaceuticals U.S.A., Inc.
|
256 | RIPE NCC | ASSIGNED PI |
| 198.102.213.0/24 |
Transkaryotic Therapies Inc.
|
256 | ARIN | ALLOCATION |
Peers
AS29207 does not have any direct peering agreements. Instead, its global connectivity is achieved through transit providers. While this setup ensures comprehensive reach, future peering could reduce latency and optimize route efficiency.
Upstreams
AS29207 connects to the global Internet via at least 6 upstream providers. In this setup, AS29207 acts as a customer, subscribing to these transit services to obtain full BGP routing information and ensure reliable, redundant access to external networks.
Downstreams
AS29207 currently has no downstream networks, meaning it does not serve as a transit provider to customer networks.